CMOEP in the Treatment of Untreated Peripheral T-cell Lymphoma
Clinical trial NCT05458180 · UNKNOWN
Trial details
- NCT number
- NCT05458180
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-07
- Primary completion
- 2024-12-15
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.